Trandolapril

Back to search

Molecule Structure

Scientific Name

Trandolapril

Description of the Drug

Trandolapril is a prodrug of an ACE inhibitor used to treat hypertension, congestive heart failure, and to improve survival following a myocardial infarction.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00519

Brand Name(s)

Gopten, Mavik, Odrik, Trandolapril

Company Owner(s)

Mylan Pharmaceuticals Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Abbvie Inc, Cipla Ltd, Teva Pharmaceuticals Usa, Epic Pharma Llc, Glenmark Generics Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Angiotensin-converting enzyme SINGLE PROTEIN INHIBITOR CHEMBL1808

Unichem Links

SureChEMBL SCHEMBL16610
PharmGKB PA451737
Human Metabolome Database HMDB0014660
WDI TRANDOLAP
DrugBank DB00519
PubChem: Thomson Pharma 14807551 14929957
PubChem 37888437 5484727
Nikkaji J33.158I
BindingDB 50369775
EPA CompTox Dashboard DTXSID2023692
DrugCentral 2712
Brenda 25040
ChemicalBook CB8682356
Guide to Pharmacology 6453
GSRS 16374163-1465-46e5-8d3d-44707169f3fe
rxnorm TRANDOLAPRIL MAVIK
PubChem: Drugs of the Future 12013675
ChEBI 9649
ZINC ZINC000001853205